{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T10:04:23Z","timestamp":1753869863561,"version":"3.41.2"},"reference-count":5,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood & Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1002\/pbc.31301","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:14:07Z","timestamp":1727673247000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changing acute myeloid leukemia into a chronic disease with long\u2010term venetoclax"],"prefix":"10.1002","volume":"71","author":[{"given":"Panagiotis","family":"Tsarouhas","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology Department of Pediatrics Akron Children's Hospital  Akron Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-2968","authenticated-orcid":false,"given":"Jeffrey","family":"Hord","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Department of Pediatrics Akron Children's Hospital  Akron Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,9,29]]},"reference":[{"key":"e_1_2_1_2_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040789"},{"key":"e_1_2_1_2_3_1","unstructured":"Center for Drug Evaluation and Research.Venetoclax (venclexta) tablets. U.S. Food and Drug Administration. Accessed August 23 2023.https:\/\/www.fda.gov\/drugs\/resources\u2010information\u2010approved\u2010drugs\/venetoclax\u2010venclexta\u2010tablets"},{"key":"e_1_2_1_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(20)30060\u20107"},{"key":"e_1_2_1_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684\u2010018\u20100635\u2010y"},{"key":"e_1_2_1_2_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01600"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T03:44:44Z","timestamp":1744256684000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.31301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,29]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1002\/pbc.31301"],"URL":"https:\/\/doi.org\/10.1002\/pbc.31301","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"type":"print","value":"1545-5009"},{"type":"electronic","value":"1545-5017"}],"subject":[],"published":{"date-parts":[[2024,9,29]]},"assertion":[{"value":"2024-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e31301"}}